Tag Archives: MPLN

April 2014—Molecular Pathology Laboratory Network, of Maryville, Tenn., acquired the Illumina MiSeqDx, a next-generation sequencing system cleared by the FDA for targeted sequencing of human genomic DNA.

January 2014—Molecular Pathology Laboratory Network has acquired the Illumina MiSeqDx and will use the system to expand testing across all of its clinical laboratories, including its clinical trials group Geneuity Clinical Research Services. MPLN is a molecular reference laboratory specializing in oncology, women’s health, and clinical research services.